4XQ7 | pdb_00004xq7

The crystal structure of the OAS-like domain (OLD) of human OASL

External Resource: Annotation

Domain Annotation: SCOP/SCOPe Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage

Chains	Domain Info	Class	Fold	Superfamily	Family	Domain	Species	Provenance Source (Version)
A	d4xq7a2	All alpha proteins	PAP/OAS1 substrate-binding domain	PAP/OAS1 substrate-binding domain	automated matches	automated matches	Human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
A	d4xq7a1	Alpha and beta proteins (a+b)	Nucleotidyltransferase	Nucleotidyltransferase	automated matches	automated matches	Human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	OAS1_C	e4xq7A2	A: alpha arrays	X: HhH/H2TH	H: SAM/DNA-glycosylase	T: PAP/OAS1 substrate-binding domain	F: OAS1_C	ECOD (1.6)
A	NTP_transf_2_1	e4xq7A1	A: a+b three layers	X: Nucleotidyltransferase-like	H: Nucleotidyltransferase (From Topology)	T: Nucleotidyltransferase	F: NTP_transf_2_1	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	3.30.460.10	Alpha Beta	2-Layer Sandwich	Beta Polymerase	domain 2	CATH (4.3.0)
A	1.10.1410.20	Mainly Alpha	Orthogonal Bundle	Poly(a)-polymerase, middle domain	2'-5'-oligoadenylate synthetase 1, domain 2	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF10421	2'-5'-oligoadenylate synthetase 1, domain 2, C-terminus (OAS1_C)	2'-5'-oligoadenylate synthetase 1, domain 2, C-terminus	This is the largely alpha-helical, C-terminal half of 2'-5'-oligoadenylate synthetase 1, being described as domain 2 of the enzyme and homologous to a tandem ubiquitin repeat. It carries the region of enzymic activity between 320 and 344 at the extre ...	This is the largely alpha-helical, C-terminal half of 2'-5'-oligoadenylate synthetase 1, being described as domain 2 of the enzyme and homologous to a tandem ubiquitin repeat. It carries the region of enzymic activity between 320 and 344 at the extreme C-terminal end [1]. Oligoadenylate synthetases are antiviral enzymes that counteract vial attack by degrading viral RNA. The enzyme uses ATP in 2'-specific nucleotidyl transfer reactions to synthesise 2'.5'-oligoadenylates, which activate latent ribonuclease, resulting in degradation of viral RNA and inhibition of virus replication [2]. This domain is often associated with NTP_transf_2 Pfam:PF01909.	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	2'-5'-oligoadenylate synthase-like protein	DNA binding binding nucleic acid binding RNA binding double-stranded RNA binding transcription factor binding RNA polymerase II-specific DNA-binding transcription factor binding nuclear receptor binding nuclear thyroid hormone receptor binding protein binding DNA-binding transcription factor binding transferase activity nucleotidyltransferase activity catalytic activity DNA binding binding nucleic acid binding RNA binding double-stranded RNA binding transcription factor binding RNA polymerase II-specific DNA-binding transcription factor binding nuclear receptor binding nuclear thyroid hormone receptor binding protein binding DNA-binding transcription factor binding transferase activity nucleotidyltransferase activity catalytic activity transferase activity, transferring phosphorus-containing groups	biological process involved in interspecies interaction between organisms response to stimulus immune response response to other organism defense response defense response to symbiont response to external stimulus response to biotic stimulus defense response to virus immune system process defense response to other organism response to stress innate immune response antiviral innate immune response biological process involved in interspecies interaction between organisms response to stimulus immune response response to other organism defense response defense response to symbiont response to external stimulus response to biotic stimulus defense response to virus immune system process defense response to other organism response to stress innate immune response antiviral innate immune response response to external biotic stimulus response to virus cellular response to stimulus regulation of biological process regulation of cellular process cell surface receptor signaling pathway signaling biological regulation response to cytokine cytokine-mediated signaling pathway cell communication response to peptide response to chemical cellular process cellular response to cytokine stimulus interleukin-27-mediated signaling pathway signal transduction negative regulation of viral genome replication negative regulation of biological process viral life cycle negative regulation of viral process regulation of viral process regulation of viral life cycle viral genome replication viral process regulation of viral genome replication positive regulation of cell communication positive regulation of response to biotic stimulus positive regulation of signal transduction pattern recognition receptor signaling pathway regulation of signal transduction intracellular signal transduction immune response-activating signaling pathway positive regulation of immune response regulation of immune system process positive regulation of immune system process innate immune response-activating signaling pathway positive regulation of pattern recognition receptor signaling pathway regulation of innate immune response positive regulation of intracellular signal transduction regulation of RIG-I signaling pathway RIG-I signaling pathway regulation of response to stimulus regulation of pattern recognition receptor signaling pathway positive regulation of defense response activation of innate immune response regulation of immune response positive regulation of RIG-I signaling pathway activation of immune response cytoplasmic pattern recognition receptor signaling pathway regulation of defense response regulation of response to biotic stimulus regulation of response to external stimulus intracellular receptor signaling pathway positive regulation of biological process regulation of cytoplasmic pattern recognition receptor signaling pathway positive regulation of response to stimulus positive regulation of response to external stimulus immune response-regulating signaling pathway regulation of intracellular signal transduction regulation of response to stress positive regulation of cellular process regulation of signaling positive regulation of innate immune response regulation of cell communication positive regulation of signaling interferon-mediated signaling pathway cellular response to type I interferon type I interferon-mediated signaling pathway response to type I interferon	membrane-bounded organelle intracellular anatomical structure nucleus membrane-enclosed lumen intracellular membraneless organelle intracellular membrane-bounded organelle nucleolus intracellular organelle lumen intracellular organelle cellular anatomical structure organelle lumen organelle membraneless organelle nuclear lumen membrane-bounded organelle intracellular anatomical structure nucleus membrane-enclosed lumen intracellular membraneless organelle intracellular membrane-bounded organelle nucleolus intracellular organelle lumen intracellular organelle cellular anatomical structure organelle lumen organelle membraneless organelle nuclear lumen membrane cytoplasm cytosol nucleoplasm

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR043518	2-5-oligoadenylate synthetase, N-terminal conserved site	Conserved Site
A	IPR006117	2-5-oligoadenylate synthetase, C-terminal conserved site	Conserved Site
A	IPR000626	Ubiquitin-like domain	Domain
A	IPR006116	2-5OAS/ClassI-CCAase, nucleotidyltransferase domain	Domain
A	IPR018952	2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal	Domain
A	IPR043519	Nucleotidyltransferase superfamily	Homologous Superfamily
A	IPR029071	Ubiquitin-like domain superfamily	Homologous Superfamily

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: Q15646	influenza maturity-onset diabetes of the young myocardial infarction ovarian cancer pancreatic intraductal papillary-mucinous neoplasm atopic eczema systemic lupus erythematosus breast cancer type 2 diabetes mellitus cystic fibrosis gallbladder disease juvenile dermatomyositis malignant mesothelioma microphthalmia with limb anomalies non-alcoholic fatty liver disease influenza maturity-onset diabetes of the young myocardial infarction ovarian cancer pancreatic intraductal papillary-mucinous neoplasm atopic eczema systemic lupus erythematosus breast cancer type 2 diabetes mellitus cystic fibrosis gallbladder disease juvenile dermatomyositis malignant mesothelioma microphthalmia with limb anomalies non-alcoholic fatty liver disease ovarian carcinoma pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia atypical teratoid rhabdoid tumor triple-negative breast carcinoma chronic obstructive pulmonary disease endogenous depression glioblastoma interstitial cystitis lung cancer malignant pancreatic neoplasm multiple sclerosis non-small cell lung carcinoma pancreatic intraductal papillary-mucinous carcinoma psoriasis Barrett esophagus tuberculosis cutaneous lupus erythematosus esophageal adenocarcinoma heart disease invasive ductal breast carcinoma lung carcinoma

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.